TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies
Brief Summary: WISER Survivor is a one year weight loss and exercise study for sedentary breast cancer survivors who are overweight or obese with breast cancer related lymphedema. There will be four groups in this trial: exercise only, weight loss only, exercise and weight-loss combined, and a control group. The primary purpose of this study is to test the effects of these interventions on clinical lymphedema outcomes. Secondary outcomes include weight loss, breast cancer related biomarkers, and quality of life. To the extent that funding will be available, participants will be followed long term to examine effects on recurrence and mortality.


Options:
A: Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: behavioral dietary and exercise intervention | Intervention Type: BEHAVIORAL; Name: behavioral dietary and exercise intervention; Assigned to Arm(s): Lifestyle counseling
B: Arm Label: Lymphedema Care Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise only; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Weight loss only; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Loss Intervention | Arm Label: Exercise and Weight loss combined; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention, Behavioral: Weight Loss Intervention | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Exercise only | Intervention Type: BEHAVIORAL; Name: Weight Loss Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Weight loss only
C: Arm Label: Arm 1: Health Education Program; Type: OTHER; Interventions: Other: Health Education Program | Arm Label: Arm 2: Health Education Program + Weight Loss Intervention; Type: OTHER; Interventions: Other: Health Education Program, Other: Weight Loss Intervention | Intervention Type: OTHER; Name: Health Education Program; Assigned to Arm(s): Arm 1: Health Education Program, Arm 2: Health Education Program + Weight Loss Intervention | Intervention Type: OTHER; Name: Weight Loss Intervention; Assigned to Arm(s): Arm 2: Health Education Program + Weight Loss Intervention
D: Arm Label: SG-WLP; Type: OTHER; Interventions: Behavioral: SG-WLP | Arm Label: MF-WLP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MF-WLP | Intervention Type: BEHAVIORAL; Name: MF-WLP; Assigned to Arm(s): MF-WLP | Intervention Type: BEHAVIORAL; Name: SG-WLP; Assigned to Arm(s): SG-WLP

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The investigators hypothesize that a three-month aerobic exercise training program will positively affect the lipid profile, insulin sensitivity , cytokine profile, the cardiovascular parameters and muscle strength in SLE patients.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Aerobic exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: Anaerobic exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Aerobic exercise group, Anaerobic exercise group
B: Arm Label: Supervised physical exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised physical exercise | Arm Label: No supervised physical exercise; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised physical exercise; Assigned to Arm(s): Supervised physical exercise
C: Arm Label: Supervised HIIT; Type: EXPERIMENTAL; Interventions: Behavioral: Effective endurance 4x4 training - Supervised | Arm Label: APP HIIT; Type: EXPERIMENTAL; Interventions: Device: Effective endurance 4x4 training - APP | Intervention Type: BEHAVIORAL; Name: Effective endurance 4x4 training - Supervised; Assigned to Arm(s): Supervised HIIT | Intervention Type: DEVICE; Name: Effective endurance 4x4 training - APP; Assigned to Arm(s): APP HIIT
D: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Healthy control; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training | Intervention Type: BEHAVIORAL; Name: Exercise training; Assigned to Arm(s): Exercise, Healthy control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder : 6-month, Randomized, Open-label, Multi-center Trial
Brief Summary: Study Objectives: To explore the effectiveness of adjunctive intervention to enhance the medication compliance and persistence in patients with Overactive Bladder (OAB), thereby to improve treatment outcomes

Study Hypothesis: Health Education Intervention (HEI) can enhance the medication compliance and persistence, thereby can improve the treatment outcomes in conjunction with pharmacological therapy in OAB patients

Study Design: 6-month, randomized, open-label, multi-center trial at 13 university hospitals


Options:
A: Arm Label: Behavioral Training; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral training | Arm Label: Drug Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxybutynin chloride, extended-release | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Behavioral Training | Intervention Type: DRUG; Name: Oxybutynin chloride, extended-release; Assigned to Arm(s): Drug Therapy
B: Arm Label: Health education intervention (HEI); Type: EXPERIMENTAL; Interventions: Behavioral: Health education intervention (HEI) | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health education intervention (HEI); Assigned to Arm(s): Health education intervention (HEI)
C: Arm Label: MyHealthebladder; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MyHealtheBladder | Arm Label: VA Video Connect; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: VA Video Connect | Intervention Type: BEHAVIORAL; Name: VA Video Connect; Assigned to Arm(s): VA Video Connect | Intervention Type: BEHAVIORAL; Name: MyHealtheBladder; Assigned to Arm(s): MyHealthebladder
D: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Structured training and leaflet | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Structured training | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Leaflet | Arm Label: Group 4; Type: SHAM_COMPARATOR; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Structured training and leaflet; Assigned to Arm(s): Group 1 | Intervention Type: BEHAVIORAL; Name: Structured training; Assigned to Arm(s): Group 2 | Intervention Type: BEHAVIORAL; Name: Leaflet; Assigned to Arm(s): Group 3 | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Group 4

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder : 6-month, Randomized, Open-label, Multi-center Trial
Brief Summary: Study Objectives: To explore the effectiveness of adjunctive intervention to enhance the medication compliance and persistence in patients with Overactive Bladder (OAB), thereby to improve treatment outcomes

Study Hypothesis: Health Education Intervention (HEI) can enhance the medication compliance and persistence, thereby can improve the treatment outcomes in conjunction with pharmacological therapy in OAB patients

Study Design: 6-month, randomized, open-label, multi-center trial at 13 university hospitals


Options:
A: Arm Label: Health education intervention (HEI); Type: EXPERIMENTAL; Interventions: Behavioral: Health education intervention (HEI) | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health education intervention (HEI); Assigned to Arm(s): Health education intervention (HEI)
B: Arm Label: Physiotherapy intervention; Type: EXPERIMENTAL; Interventions: Other: Physiotherapy intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physiotherapy intervention; Assigned to Arm(s): Physiotherapy intervention
C: Arm Label: bladdertraining group; Type: EXPERIMENTAL; Interventions: Behavioral: bladdertraining in groups | Arm Label: bladdertraining individually; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: bladdertraining individually | Intervention Type: BEHAVIORAL; Name: bladdertraining in groups; Assigned to Arm(s): bladdertraining group | Intervention Type: BEHAVIORAL; Name: bladdertraining individually; Assigned to Arm(s): bladdertraining individually
D: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise classes with pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise classes with pelvic floor muscle training; Assigned to Arm(s): Exercise group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Home-Based Therapy for Symptomatic Convergence Insufficiency
Brief Summary: The purpose of this study is to determine the effectiveness of home-based computer therapy for symptomatic convergence insufficiency (CI) compared to traditional home-based near target push-ups and placebo treatment.


Options:
A: Arm Label: Computer-based therapy (CBT); Type: ACTIVE_COMPARATOR; Interventions: Other: Active home-based computer vergence/accommodative therapy, Procedure: Placebo yoked prism flippers | Arm Label: Near target push-up (NTP); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Near target push-ups, Other: Placebo home-based computer vergence/accommodative therapy | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo home-based computer vergence/accommodative therapy, Procedure: Placebo yoked prism flippers | Intervention Type: OTHER; Name: Active home-based computer vergence/accommodative therapy; Assigned to Arm(s): Computer-based therapy (CBT) | Intervention Type: PROCEDURE; Name: Near target push-ups; Assigned to Arm(s): Near target push-up (NTP) | Intervention Type: OTHER; Name: Placebo home-based computer vergence/accommodative therapy; Assigned to Arm(s): Near target push-up (NTP), Placebo | Intervention Type: PROCEDURE; Name: Placebo yoked prism flippers; Assigned to Arm(s): Computer-based therapy (CBT), Placebo
B: Intervention Type: PROCEDURE; Name: Pencil Push-ups; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Office-based Vision Therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Placebo Office-based Vision Therapy; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: Base-in prism glasses for reading; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Placebo reading glasses; Assigned to Arm(s): N/A
D: Arm Label: home-based vision orthoptic therapy (HBVOT) group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: trained to do the pencil push-ups procedure | Arm Label: office-based vision orthoptic therapy (OBVOT) group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: using a major amblyoscope twice weekly with additional home orthoptic therapy | Arm Label: augmented office-based vision orthoptic therapy (AOBVOT) group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: using three diopter over-minus lenses and a base out prism | Intervention Type: PROCEDURE; Name: trained to do the pencil push-ups procedure; Assigned to Arm(s): home-based vision orthoptic therapy (HBVOT) group | Intervention Type: PROCEDURE; Name: using a major amblyoscope twice weekly with additional home orthoptic therapy; Assigned to Arm(s): office-based vision orthoptic therapy (OBVOT) group | Intervention Type: PROCEDURE; Name: using three diopter over-minus lenses and a base out prism; Assigned to Arm(s): augmented office-based vision orthoptic therapy (AOBVOT) group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Healthy Lifestyles Using Mobile Phones
Brief Summary: The purpose of this research is to test programs to increase physical activity and reduce sedentary behavior using motivational messages over a cell phone.


Options:
A: Arm Label: MIPARC intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity, Behavioral: Group educational sessions, Behavioral: Phone counseling call, Behavioral: Peer Mentoring, Behavioral: Policy Change, Behavioral: Support, Behavioral: Tailored environmental resources | Arm Label: Health Education Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group educational sessions, Behavioral: Health check phone call, Behavioral: Pedometer | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Group educational sessions; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Phone counseling call; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Peer Mentoring; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Policy Change; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Support; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Tailored environmental resources; Assigned to Arm(s): MIPARC intervention | Intervention Type: BEHAVIORAL; Name: Group educational sessions; Assigned to Arm(s): Health Education Control | Intervention Type: BEHAVIORAL; Name: Health check phone call; Assigned to Arm(s): Health Education Control | Intervention Type: BEHAVIORAL; Name: Pedometer; Assigned to Arm(s): Health Education Control
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: Behavioral: website assess | Intervention Type: BEHAVIORAL; Name: website assess; Assigned to Arm(s): Control group
C: Arm Label: Exercise programme only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise programme plus SMS reminders | Intervention Type: BEHAVIORAL; Name: Exercise programme plus SMS reminders; Assigned to Arm(s): SMS reminder
D: Arm Label: Cognitive app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Social app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Affect app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Nutrition app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Intervention Type: BEHAVIORAL; Name: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford; Assigned to Arm(s): Affect app, Cognitive app, Nutrition app, Social app

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation Via Text Messaging: Feasibility Testing of SMS USA
Brief Summary: The investigators developed a text messaging-based smoking cessation program called SMS (Stop My Smoking) USA. It was tailored for the unique needs and smoking habits of young adults. The investigators hypothesized that those in the SMS USA intervention would be significantly more likely to be quit at 6-months compared to the attention-matched control group.


Options:
A: Arm Label: SMS USA; Type: EXPERIMENTAL; Interventions: Behavioral: SMS USA | Arm Label: Attention matched control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS USA; Assigned to Arm(s): SMS USA
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Photoaging mobile app promoting poster campaign. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Photoaging mobile app promoting poster campaign.; Assigned to Arm(s): Intervention
C: Arm Label: Bupropion SR + Contingency Management; Type: EXPERIMENTAL; Interventions: Drug: Bupropion SR, Behavioral: Contingency Management | Arm Label: Placebo + Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Contingency Management, Other: Placebo | Arm Label: Bupropion SR + No Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion SR | Arm Label: Placebo + No Contingency Management; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Bupropion SR; Assigned to Arm(s): Bupropion SR + Contingency Management, Bupropion SR + No Contingency Management | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Bupropion SR + Contingency Management, Placebo + Contingency Management | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo + Contingency Management, Placebo + No Contingency Management
D: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Open-label, Parallel-group, Active-controlled Study of Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism, With or Without Symptomatic Deep Vein Thrombosis
Brief Summary: The objective of this study is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of rivaroxaban in the treatment of pulmonary embolism (PE) and the prevention of the occurrence and the recurrence of deep vein thrombosis (DVT) or PE in Japanese patients with acute symptomatic PE with or without symptomatic DVT.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939) | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated heparin | Arm Label: Arm 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Rivaroxaban (Xarelto, BAY59-7939); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Unfractionated heparin; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Arm 3
B: Arm Label: Rivaroxaban (Xarelto, BAY59-7939); Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rivaroxaban (Xarelto, BAY59-7939); Assigned to Arm(s): Rivaroxaban (Xarelto, BAY59-7939) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Active ECS; Type: ACTIVE_COMPARATOR; Interventions: Device: Knee-length, graduated elastic compression stocking | Arm Label: Placebo ECS; Type: PLACEBO_COMPARATOR; Interventions: Device: Knee-length, placebo stocking | Intervention Type: DEVICE; Name: Knee-length, graduated elastic compression stocking; Assigned to Arm(s): Active ECS | Intervention Type: DEVICE; Name: Knee-length, placebo stocking; Assigned to Arm(s): Placebo ECS
D: Arm Label: Dabigatran etexilate (150mg bid); Type: EXPERIMENTAL; Interventions: Drug: Dabigatran etexilate | Arm Label: Warfarin (INR 2.0-3.0); Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Warfarin (INR 2.0-3.0) | Intervention Type: DRUG; Name: Dabigatran etexilate; Assigned to Arm(s): Dabigatran etexilate (150mg bid)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Open-label, Parallel-group, Active-controlled Study of Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism, With or Without Symptomatic Deep Vein Thrombosis
Brief Summary: The objective of this study is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of rivaroxaban in the treatment of pulmonary embolism (PE) and the prevention of the occurrence and the recurrence of deep vein thrombosis (DVT) or PE in Japanese patients with acute symptomatic PE with or without symptomatic DVT.


Options:
A: Arm Label: Low-molecular-weight heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low-molecular-weight heparin | Arm Label: Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban | Intervention Type: DRUG; Name: rivaroxaban; Assigned to Arm(s): Rivaroxaban | Intervention Type: DRUG; Name: Low-molecular-weight heparin; Assigned to Arm(s): Low-molecular-weight heparin
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939) | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated heparin | Arm Label: Arm 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Rivaroxaban (Xarelto, BAY59-7939); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Unfractionated heparin; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Arm 3
C: Arm Label: Arm I (apixaban); Type: EXPERIMENTAL; Interventions: Drug: Apixaban, Other: Questionnaire Administration | Arm Label: Arm II (dalteparin); Type: EXPERIMENTAL; Interventions: Drug: Dalteparin, Other: Questionnaire Administration | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): Arm I (apixaban) | Intervention Type: DRUG; Name: Dalteparin; Assigned to Arm(s): Arm II (dalteparin) | Intervention Type: OTHER; Name: Questionnaire Administration; Assigned to Arm(s): Arm I (apixaban), Arm II (dalteparin)
D: Arm Label: BAY59-7939; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939) | Arm Label: Standard of Care; Type: EXPERIMENTAL; Interventions: Drug: Standard of Care | Intervention Type: DRUG; Name: Rivaroxaban (Xarelto, BAY59-7939); Assigned to Arm(s): BAY59-7939 | Intervention Type: DRUG; Name: Rivaroxaban (Xarelto, BAY59-7939); Assigned to Arm(s): BAY59-7939 | Intervention Type: DRUG; Name: Standard of Care; Assigned to Arm(s): Standard of Care

Answer: B